Roop K. Lakkaraju - 24 Apr 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Chief Financial Officer
Signature
/s/ Roop K. Lakkaraju
Issuer symbol
BIO
Transactions as of
24 Apr 2025
Net transactions value
-$96,400
Form type
4
Filing time
25 Apr 2025, 18:07:10 UTC
Previous filing
05 Mar 2025
Next filing
09 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +1,077 +698% $0.000000 1,231 24 Apr 2025 Direct F1, F2
transaction BIO BIOB Bio-Rad A Common Stock Tax liability $96,400 -386 -31% $249.74 845 24 Apr 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -1,077 -25% $0.000000 3,234 24 Apr 2025 Bio-Rad A Common Stock 1,077 $0.000000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 66.8810 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2025.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 On April 24, 2024, the reporting person was granted 4,311 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.